Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Claude Libert
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
68
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor-spokesperson
01 January 2019 → 31 December 2023
Elucidating the details of the interaction between specific nutrients-microbiota-intestinal health and the consequences for inflammatory diseases
Funding: Regional and community funding: Special Research Fund
01 October 2020 → 30 September 2024
Promoting intestinal health by modulating the Zinc-microbiome axis at the Paneth cell level (acronym: ZIPAM)
Funding: Research Foundation - Flanders (FWO)
As
Promotor
01 July 2011 → 30 April 2016
A detailed study of the role of SRC-1A and SRC-2 (GRP-1) in TNF-induced Glucocorticoid Resistance
Funding: Regional and community funding: Special Research Fund
01 October 2015 → 30 September 2019
Analysis of the effect of caloric restriction on the choroid plexus epithelial (CPE) cells that form the blood-cerebrospinal fluid barrier (BCSFB).
Fellow: Charysse Vandendriessche
Funding: Research Foundation - Flanders (FWO)
01 October 2015 → 30 September 2020
Application of novel tools and insights to understand the exact role of TNF in polymicrobial sepsis and to develop an efficient therapy.
Fellow: Jolien Vandewalle
Funding: Research Foundation - Flanders (FWO)
01 January 2010 → 31 December 2015
A profound study of the anti-inflammatory condition of the mouse strain SPRET/Ei, with emphasis on the glucocorticoidreceptor and the X chromosome
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2019
A profound study of the mechanism and field of application of the increase of Glucocorticoid Receptor transcriptional activity by zinc.
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2019
A profound study of the pro-inflammatory activities of MMPs
Funding: Research Foundation - Flanders (FWO)
01 January 2011 → 31 December 2014
A profound study of the pro-inflammatory activities of MMPs
Funding: Research Foundation - Flanders (FWO)
01 January 2021 → 31 December 2024
Autophagy in inflammation and inflammatory disorders (ATLANTIS), from basic insights to experimental therapy
Funding: Regional and community funding: Special Research Fund
01 January 2011 → 31 December 2014
Circumventing the Biological Obstacles of anti-inflammatory Glucocorticoid Therapy
Funding: Regional and community funding: various
01 January 2008 → 30 December 2012
Deatailed analysis of the resistance against inflammation of Mus spretus by means of genomic techniques
Funding: Research Foundation - Flanders (FWO)
01 January 2008 → 31 December 2010
Derivation of embryonic stem cells from SPRET/Ei, an inbred strain from the wild species Mus spretus
Funding: Research Foundation - Flanders (FWO)
01 October 2010 → 05 January 2016
Detailed studie of the role of type-I IFN in TNF-induced and TNF-mediated pathologies
Fellows: Lynda Grine
Funding: Regional and community funding: IWT/VLAIO
01 October 2009 → 26 February 2015
Detailed study of the molecular basis of TNF-induced glucocorticoid resistance
Fellow: Sofie Vandevyver
Funding: Regional and community funding: IWT/VLAIO
01 January 2020 → 31 December 2023
Developing a broadly protecting vaccine against polymicrobial sepsis.
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2016
Development of alphaVBeta3 nanobodies as novel cancer therapy
Funding: Funding by bilateral agreement (private and foundations)
01 January 2011 → 31 December 2014
Development of TNF as a drastic and safe anti-cancer therapy
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 30 December 2012
Endotoxemia and gram-nagative sepsis: fundamental research to identify new mediators and new therapeutic targets
Funding: Research Foundation - Flanders (FWO)
01 October 2015 → 30 September 2019
Generation and detailed analysis of novel tools to study the importance of dimerization of the Glucocorticoid Receptor in inflammation.
Fellow: Lise Van Wyngene
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2017
Generation and detailed analysis of novel tools to study the importance of dimerization of the Glucocorticoid Receptor in inflammation.
Funding: Research Foundation - Flanders (FWO)
01 January 2019 → 31 December 2022
Generation, characterization and use of immortalized Paneth cells, to elucidate and mimic the therapeutic mechanism of Zinc against infections.
Fellow: Charlotte Wallaeys
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 31 December 2010
Generation, validation and application of nanobodies directed against the neovascular integrins alpha V and Beta 3 in cancer therapie
Funding: Funding by bilateral agreement (private and foundations)
01 December 2007 → 30 November 2009
Glycomics monitoring of HCC, fibrosis and cirrhossis in chinese patients infected with hepatitis
Funding: Federal funding: various
01 January 2013 → 31 December 2015
Identification of novel therapeutic targets for the prevention of epithelial blood-CSF barrier disruption in systemic inflammatory diseases
Fellow: Roosmarijn Vandenbroucke
Funding: Research Foundation - Flanders (FWO)
01 October 2013 → 31 December 2017
Inhibition of TNF-induced inflammation by glucocorticoids via induction of microRNAs
Fellow: Jolien Souffriau
Funding: Regional and community funding: IWT/VLAIO
01 October 2013 → 25 March 2018
Inhibition of TNFR1 for the treatment of TNF mediated diseases
Fellow: Filip Van Hauwermeiren
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2014 → 31 December 2016
Inhibition of TNFR1 for the treatment of TNF-mediated pathologies
Funding: Research Foundation - Flanders (FWO)
01 October 2023 → 30 September 2026
Investigating the protective role of the glucocorticoid receptor against lactate-mediated lethal shock in sepsis
Fellow: Jolien Vandewalle
Funding: Research Foundation - Flanders (FWO)
01 November 2023 → 31 October 2027
Investigating the role of hemolysis in polymicrobial sepsis.
Fellow: Marah Heyerick
Funding: Research Foundation - Flanders (FWO)
01 October 2023 → 31 October 2023
Investigating the role of hemolysis in polymicrobial sepsis.
Fellow: Marah Heyerick
Funding: Regional and community funding: Special Research Fund
01 November 2021 → 31 October 2025
Investigating the role of lactate-mediated lethal shock in sepsis.
Fellow: Louise Nuyttens
Funding: Research Foundation - Flanders (FWO)
01 January 2021 → 31 December 2024
Investigation of the mechanism of the loss of function of HNF4a-PPARa axis in polymicrobial sepsis.
Funding: Research Foundation - Flanders (FWO)
01 October 2009 → 11 November 2014
Matrix metalloproteinases in inflammatory diseases: therapeutic and functional study.
Fellow: Roosmarijn Vandenbroucke
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2010 → 31 December 2012
Matrix Metalloproteinases (MMP’s) in inflammatory diseases: therapeuytic and functional studies
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 October 2018
Novel anti-inflammatory mechanisms of glucocorticoids – towards a higher safety and efficacy
Funding: Regional and community funding: Special Research Fund
01 January 2014 → 31 December 2014
Optimisation of a aVB3 targeted Nanobodies for cancer therapy, cancer imaging and targeted delivery.
Funding: Funding by bilateral agreement (private and foundations)
01 October 2012 → 14 June 2013
Profound study of blood-brain and blood-CSF barrier disruption in systemic inflammatory disorders
Fellow: Sophie Steeland
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2018
Profound study of the anti-inflammatory mechanism and therapeutic significance of GILZ in endotocemia ans sepsis.
Funding: Research Foundation - Flanders (FWO)
01 October 2008 → 01 October 2009
Profound study of the function of several matrix metalloproteinases (MMPs) in innate immunity, amongst others against bacterial infections
Funding: Regional and community funding: Special Research Fund
01 January 2011 → 31 December 2013
Profound study of the molecular basis of TNF-induced glucocorticoid resistance
Funding: Research Foundation - Flanders (FWO)
01 October 2011 → 30 November 2014
Profound study on the molecular basis of TNF-induced glucocorticoid resistance
Fellow: Lien Dejager
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
10 February 2008 → 30 September 2009
Research into the role of the matrix metalloproteinases, and more specifically, MMP7, endotoxemia in
Fellow: Ineke Vanlaere
Funding: Research Foundation - Flanders (FWO)
01 September 2011 → 31 December 2013
Resolving the glucocorticoid resistance of severe asthma
Funding: Funding by bilateral agreement (private and foundations)
01 January 2014 → 30 November 2014
Role of non-coding RNAs in the anti-inflammatory actions of glucocorticoids
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2017
Search for new therapeutic strategies to treat Alzheimer's disease: development of an in vitro system for high throughput compound screening based on choroid plexus epithelium.
Funding: Research Foundation - Flanders (FWO)
01 January 2021 → 31 December 2027
STOP SEPSIS
Funding: Regional and community funding: Special Research Fund
01 October 2021 → 30 September 2025
STOP_SEPSIS: investigation into a new concept of sepsis, the greatest unmet medical need of our times.
Funding: Research Foundation - Flanders (FWO)
01 October 2007 → 31 May 2010
Study for the role of type I and III interferons in endotoxemia and sepsis
Fellow: Liesbeth Huys
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 October 2010 → 30 September 2013
Study of the aging process: the role of N-glycosylation, hormones and the Klotho gene.
Fellow: Valerie Vanhooren
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 14 June 2016
Study of the involvement of the choroid plexus during SIRS
Fellow: Delphine Demeestere
Funding: Regional and community funding: IWT/VLAIO
01 October 2007 → 30 September 2008
Study of transversal ompuls and spin degrees of freedom in ucleon structure with semi-inclusive deep inelastic scattering in HERMES. Study of high energy cosmic rays through the observation v.atmosferische neutrinos in Icecube.
Fellow: Lien Dejager
Funding: Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2019
Study on the effects of HDAC inhibitors on the transcriptional activity of the glucocorticoid receptor.
Fellow: Kelly Van Looveren
Funding: Research Foundation - Flanders (FWO)
01 January 2022 → 31 December 2025
Taking IBD Genes from GWAS to Function to Drug Target
Funding: Research Foundation - Flanders (FWO)
01 January 2011 → 31 December 2011
The development of a robust and safe anticancer therapy based on TNF and interferon
Funding: Funding by bilateral agreement (private and foundations)
01 October 2013 → 23 October 2017
The development of strong specific, efficient, flexible and safe TNF-receptor inhibitors for treatment of acute and chronic inflammatory diseases.
Fellow: Sophie Steeland
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2012 → 31 December 2017
The interactions between the brain and MMP8 and MMP3 in systemic inflammation
Funding: Research Foundation - Flanders (FWO)
01 October 2022 → 30 September 2026
The role of HNF4α and hepatocyte de-differentiation in sepsis
Funding: Regional and community funding: Special Research Fund
01 October 2013 → 30 September 2017
The role of RNA in the TNF-induced reduced DNA binding of the glucocorticoid Receptor
Fellow: Karen Dendoncker
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2014 → 31 December 2019
The role of TNF Receptor-1 regulating microRNA's in inflammation
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2018
Towards a substantial increase in therapeutic index of TNF
Funding: Research Foundation - Flanders (FWO)
01 November 2020 → 19 November 2021
Understanding the anti-diarrhea effects of zinc at the Paneth cell level.
Fellow: Lindsy Aelbrecht
Funding: Research Foundation - Flanders (FWO)
01 November 2021 → 31 October 2025
Understanding the role of nuclear receptor HNF4a in sepsis and unravel the mechanisms of its loss-of-function in relation to PPARa failure.
Fellow: Céline Van Dender
Funding: Research Foundation - Flanders (FWO)
01 January 2017 → 31 December 2019
Unraveling the effect of caloric restriction on gene expression in the choroid plexus and correlation with extracellular vesicle production and cognition in mouse models of age-related Alzheimer’ disease
Funding: Research Foundation - Flanders (FWO)
As
Copromotor
01 October 2014 → 30 September 2018
Effect of Helicobacter suis infection to the onset of neurodegenerative diseases in humans.
Funding: Regional and community funding: Special Research Fund
01 May 2024 → 30 April 2028
FullPicture: Combining Spectral Flow Cytometry with High-Speed Cell Imaging to enable comprehensive profiling of plant and animal cells and their components in real time.
Funding: Research Foundation - Flanders (FWO)
01 November 2023 → 31 October 2027
Integrative interactome and protein modification analysis of HNF4α in sepsis
Fellow: Madeleine Hellemans
Funding: Research Foundation - Flanders (FWO)
01 December 2020 → 30 November 2022
Replacement and extension of basic infrastructure in the histology core facility.
Funding: Regional and community funding: Special Research Fund